Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Use of liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in neoadjuvant pancreatic adenocarcinoma: NEO-Nal-IRI trial.
Journal: The oncologist
Published: February 09, 2026
Patient-reported outcomes (PROs) in NRG Oncology RTOG 0436: a phase III trial evaluating the addition of cetuximab to paclitaxel, cisplatin, and radiation for esophageal cancer treated without surgery.
Journal: Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation
Published: July 11, 2024
A phase II study of neoadjuvant liposomal irinotecan with 5-FU and oxaliplatin (NALIRIFOX) in pancreatic adenocarcinoma.
Journal: Future oncology (London, England)
Published: September 27, 2023
Hypercalcemia Resulting from Necrotizing Leiomyoma in a Pregnant Female.
Journal: The American journal of case reports
Published: August 06, 2020
Germline BAP1 mutation in a family with high incidence of multiple primary cancers and a potential gene-environment interaction.
Journal: Cancer letters
Published: July 22, 2015
Safety and activity of alisertib, an investigational aurora kinase A inhibitor, in patients with breast cancer, small-cell lung cancer, non-small-cell lung cancer, head and neck squamous-cell carcinoma, and gastro-oesophageal adenocarcinoma: a five-arm phase 2 study.
Journal: The Lancet. Oncology
Published: March 03, 2015
Successful gestation and delivery using clopidogrel for secondary stroke prophylaxis: a case report and literature review.
Journal: Archives of gynecology and obstetrics
Published: April 14, 2014
S0941: a phase 2 SWOG study of sorafenib and erlotinib in patients with advanced gallbladder carcinoma or cholangiocarcinoma.
Journal: British journal of cancer
Published: July 23, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026